New drug shows promise for reversing lung artery damage in PAH patients
NCT ID NCT07487441
First seen Apr 02, 2026 · Last updated May 04, 2026 · Updated 6 times
Summary
This study looks at whether the drug sotatercept can help repair damaged blood vessels in the lungs of people with pulmonary arterial hypertension (PAH). Researchers will use special imaging to see if the arteries become healthier over time. About 30 adults with PAH will take part, and the goal is to understand how the drug works rather than to cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Clinical and Translational Sciences Research Center
Tucson, Arizona, 85724, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.